AU2001260847A1 - Compositions isolated from skin cells and methods for their use - Google Patents
Compositions isolated from skin cells and methods for their useInfo
- Publication number
- AU2001260847A1 AU2001260847A1 AU2001260847A AU6084701A AU2001260847A1 AU 2001260847 A1 AU2001260847 A1 AU 2001260847A1 AU 2001260847 A AU2001260847 A AU 2001260847A AU 6084701 A AU6084701 A AU 6084701A AU 2001260847 A1 AU2001260847 A1 AU 2001260847A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- skin cells
- compositions isolated
- isolated
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
- 210000004927 skin cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20665000P | 2000-05-24 | 2000-05-24 | |
US60206650 | 2000-05-24 | ||
US22123200P | 2000-07-25 | 2000-07-25 | |
US60221232 | 2000-07-25 | ||
PCT/NZ2001/000099 WO2001090357A1 (en) | 2000-05-24 | 2001-05-24 | Compositions isolated from skin cells and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001260847A1 true AU2001260847A1 (en) | 2001-12-03 |
Family
ID=26901556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001260847A Abandoned AU2001260847A1 (en) | 2000-05-24 | 2001-05-24 | Compositions isolated from skin cells and methods for their use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001260847A1 (en) |
WO (1) | WO2001090357A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1254246A4 (en) * | 2000-01-25 | 2003-05-21 | Hyseq Inc | Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
US20020146763A1 (en) * | 2000-07-06 | 2002-10-10 | Zeren Gao | Murine cytokine receptor |
WO2002010217A2 (en) | 2000-08-02 | 2002-02-07 | The Johns Hopkins University | Endothelial cell expression patterns |
US20040171109A1 (en) * | 2000-11-10 | 2004-09-02 | Dominik Haudenschild | IL-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage |
US20020111302A1 (en) * | 2000-11-30 | 2002-08-15 | Y. Tom Tang | Novel nucleic acids and polypeptides |
US7118912B2 (en) | 2002-08-26 | 2006-10-10 | Case Western Reserve University | Methods and compositions for categorizing patients |
US20060035237A1 (en) | 2002-08-26 | 2006-02-16 | Markowitz Sanford D | Methods and compositions for categorizing patients |
US7081516B2 (en) | 2002-08-26 | 2006-07-25 | Case Western Reserve University | Methods for categorizing patients |
CA2476556A1 (en) * | 2002-02-13 | 2003-08-21 | Duke University | Modulation of immune response by non-peptide binding stress response polypeptides |
AU2003236351A1 (en) * | 2002-04-03 | 2003-10-27 | Banyu Pharmaceutical Co., Ltd. | Novel g protein-coupled receptor gene and protein bg8 |
WO2004001060A2 (en) | 2002-06-20 | 2003-12-31 | Bristol-Myers Squibb Company | Identification and regulation of a g-protein coupled receptor, rai-3 |
WO2004007711A1 (en) * | 2002-07-10 | 2004-01-22 | Takeda Pharmaceutical Company Limited | Novel proteins and use thereof |
TW200418979A (en) * | 2002-11-06 | 2004-10-01 | Hayashibara Biochem Lab | Physiologically active polypeptide and its antibody and use thereof |
DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
US20050158308A1 (en) * | 2003-12-22 | 2005-07-21 | Amgen Inc. A Corporation Of The State Of Delaware | HEH4 molecules and uses thereof |
DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
BRPI0511952A (en) | 2004-06-10 | 2008-01-29 | Zymogenetics Inc | isolated soluble receptor, antibody or antibody fragment, and methods of reducing il-17a-induced or il-17f-induced inflammation, treating an affected mammal with an inflammatory disease, and a pathological condition in an individual associated with zcytor activity14 |
EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
WO2008039553A1 (en) | 2006-02-10 | 2008-04-03 | Zymogenetics, Inc. | Soluble il-17rcx4 and methods of using in inflammation |
EP2198306A1 (en) | 2007-09-06 | 2010-06-23 | Case Western Reserve University | Methods for diagnosing and treating cancers |
EP2107068A1 (en) * | 2008-03-31 | 2009-10-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | MZB1, a novel B cell factor, and uses thereof |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
KR102643443B1 (en) | 2012-11-13 | 2024-03-06 | 비온테크 에스이 | Agents for treatment of claudin expressing cancer diseases |
WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
CN111836635A (en) * | 2018-01-26 | 2020-10-27 | 剑桥企业有限公司 | Peptide exchange proteins |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5850020A (en) * | 1996-09-11 | 1998-12-15 | Genesis Research & Development Corporation, Ltd. | Materials and method for the modification of plant lignin content |
DE19817557A1 (en) * | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Human nucleic acid sequences from ovarian tumor tissue |
US6573095B1 (en) * | 1998-04-29 | 2003-06-03 | Genesis Research & Development Corporation Limited | Polynucleotides isolated from skin cells |
CN1158386C (en) * | 1998-04-29 | 2004-07-21 | 吉尼西斯研究及发展有限公司 | Polynucleotides isolated from skin cells and methods for their use |
CA2351522A1 (en) * | 1998-11-19 | 2000-05-25 | Samantha Busfield | Egf-like nucleic acids and polypeptides and uses thereof |
GB9828840D0 (en) * | 1998-12-30 | 1999-02-17 | Univ Nottingham Trent | Prostate cancer associated genes and their products |
WO2000063230A2 (en) * | 1999-03-26 | 2000-10-26 | Human Genome Sciences, Inc. | 49 human secreted proteins |
CA2370609A1 (en) * | 1999-04-20 | 2000-10-26 | Zymogenetics, Inc. | Adipocyte complement related protein homolog zacrp3 |
AU5159500A (en) * | 1999-05-27 | 2000-12-18 | Zymogenetics Inc. | Adipocyte complement related protein homolog zacrp7 |
EP1067182A3 (en) * | 1999-07-08 | 2001-11-21 | Helix Research Institute | Secretory protein or membrane protein |
WO2001007612A2 (en) * | 1999-07-21 | 2001-02-01 | Incyte Genomics, Inc. | Receptors and associated proteins |
JP2003508030A (en) * | 1999-08-11 | 2003-03-04 | キュラジェン コーポレイション | Novel polypeptide and nucleic acid encoding the same |
GB9921785D0 (en) * | 1999-09-16 | 1999-11-17 | Univ Robert Gordon | Apparatus and method |
-
2001
- 2001-05-24 AU AU2001260847A patent/AU2001260847A1/en not_active Abandoned
- 2001-05-24 WO PCT/NZ2001/000099 patent/WO2001090357A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001090357A1 (en) | 2001-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001260847A1 (en) | Compositions isolated from skin cells and methods for their use | |
AUPQ419099A0 (en) | Novel compositions and methods | |
AU2778801A (en) | Antisense compositions and methods | |
AU2001282877A1 (en) | Cosmetic compositions | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2911100A (en) | Skin cosmetic composition | |
AU3976200A (en) | Cosmetic compositions | |
AU2001265919A1 (en) | Cosmetic compositions | |
AU2001253255A1 (en) | Compositions and methods for inhibiting gene expression | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU2001238363A1 (en) | Compositions for preventing cellulite in mammalian skin | |
EP1185555A4 (en) | Compositions isolated from skin cells and methods for their use | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU2035300A (en) | Initiator compositions and methods for their synthesis and use | |
AU2001271031A1 (en) | Cosmetic compositions for reducing and method of using the same | |
AU5647601A (en) | Hair treatment compositions | |
AU7373000A (en) | Cosmetic compositions | |
AU2001232866A1 (en) | Skin care compositions | |
AU1152601A (en) | Compositions and their use | |
AU2002216223A1 (en) | Preservation of cells | |
AU2002201A (en) | Cosmetic compositions and methods for lightening the skin | |
AU6094200A (en) | Nor gene compositions and methods for use thereof | |
AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
AU5640500A (en) | Cosmetic compositions | |
AU5770100A (en) | Cosmetic compositions |